Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Familial myeloid malignancies with germline TET2 mutation.

Leukemia - 1 May 2020

Duployez Nicolas, Goursaud Laure, Fenwarth Laurène, Bories Claire, Marceau-Renaut Alice, Boyer Thomas, Fournier Elise, Nibourel Olivier, Roche-Lestienne Catherine, Huet Guillemette, Beauvais David, Berthon Céline, Cambier Nathalie, Quesnel Bruno, Preudhomme Claude

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dioxygenases
Share to Frameshift Mutation
Share to Germ-Line Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to Leukemia, Myeloid, Acute

Share to Leukemia, Myelomonocytic, Chronic

Share to Lymphoma, T-Cell

Share to Proto-Oncogene Proteins

Source

Identifiers

PMID: 31827242
DOI: 10.1038/s41375-019-0675-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Familial myeloid malignancies with germline TET2 mutation.PMID 31827242Read ↗

[Mutations in TET2 in myeloid cancers].Semantic proximity Read ↗

[TET2 dysregulation in hematologic malignancies].Semantic proximity Read ↗

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisSemantic proximity Read ↗

Landscape of TET2 Mutations: From Hematological Malignancies to Solid TumorsSemantic proximity Read ↗

Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.Semantic proximity Read ↗

Pedigree Investigation, Clinical Characteristics and Prognosis Analysis of Hematological Disease Patients with Germline TET2 MutationSemantic proximity Read ↗

Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.Semantic proximity Read ↗

TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemiaSemantic proximity Read ↗

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.Semantic proximity Read ↗

Germline CHEK2 mutations in patients with myeloid neoplasms.Semantic proximity Read ↗

Research Advances in the Mutation of TET2 Gene in Myeloid Maligancies.Semantic proximity Read ↗

TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.